| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 10/05/2006 | WO2006023608A3 Growth-hormone secretagogues |
| 10/05/2006 | WO2006014292A3 Oral vaccine for borrelia |
| 10/05/2006 | WO2005117561A3 Compositions and methods for diagnosing and treating diseases using low density lipoprotein-like lipid emulsions |
| 10/05/2006 | WO2005112983A3 Modulation of immunoglobulin production and atopic disorders |
| 10/05/2006 | WO2005097168A3 Synthetic chemokines, methods of manufacture, and uses |
| 10/05/2006 | WO2005084390A3 Partially loaded antibodies and methods of their conjugation |
| 10/05/2006 | WO2005080338A8 New pharmaceutical compositions based on benzilic acid esters and soluble tnf receptor fusion proteins |
| 10/05/2006 | WO2005032344A3 Human prostate cancer cell factor(s) that induce stem cell commitment and osteogenesis |
| 10/05/2006 | WO2004065576A3 Methods and compositions for the treatment of urological disorder using differential expressed polypeptides |
| 10/05/2006 | WO2004046317A3 Products and processes for modulating peptide-peptide binding domain interactions |
| 10/05/2006 | WO2004044163A3 Methods for identifying risk of melanoma and treatments thereof |
| 10/05/2006 | WO2004039832A3 Leptin-related peptides |
| 10/05/2006 | WO2004022705A3 Neurotransmission-associated proteins |
| 10/05/2006 | WO2004016736A3 Nucleic acids and corresponding proteins entitled 202p5a5 useful in treatment and detection of cancer |
| 10/05/2006 | WO2003106643A8 Novel polynucleotides encoding lamprey gnrh-iii |
| 10/05/2006 | US20060223990 Synthesis, deprotection, analysis & purification of RNA & ribozymes |
| 10/05/2006 | US20060223987 Neutrophil specific immunoglobulins for use in treatment and prevention of microbial infection |
| 10/05/2006 | US20060223984 Gamma-conopeptides |
| 10/05/2006 | US20060223983 Lipopeptide stereoisomers, methods for preparing same and useful intermediates |
| 10/05/2006 | US20060223779 Method of screening for inhibitors of human Fatty Acid-CoA Ligase 4 |
| 10/05/2006 | US20060223775 Nucleotide sequence for treating cancer and infection |
| 10/05/2006 | US20060223774 therapy for bacteria infections which ar drug resistance, antibiotic resistance; anticancer agents; hybrid nucleic acid |
| 10/05/2006 | US20060223771 Nuclear factor kappaB inducing factor |
| 10/05/2006 | US20060223769 Vaccines using nucleic acid-lipid complexes |
| 10/05/2006 | US20060223768 Regulation of gene expression |
| 10/05/2006 | US20060223761 Methods and compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| 10/05/2006 | US20060223760 Compositions and methods for treatment of cancer |
| 10/05/2006 | US20060223759 Substituted 1,2-ethylenediamines, Methods for Preparing Them and Uses Thereof |
| 10/05/2006 | US20060223758 Treating treating angiogenic disease by administering therapeutically effective amount of compounds of the invention, for example, {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester; stability |
| 10/05/2006 | US20060223757 Applications in gene therapy, transgenic organisms, functional genomics, and other areas of cell and molecular biology. |
| 10/05/2006 | US20060223756 Endothelial cell specifically binding peptides |
| 10/05/2006 | US20060223755 biodrug having affinity to bacterial and fungal toxins, and especially to lipopolysaccharide or lipoteichoic acid; treating a fungal or bacterial infection; ear infection, upper respiratory infection, sinusitis, otitis |
| 10/05/2006 | US20060223754 Human TSLP polynucleotides |
| 10/05/2006 | US20060223753 exhibiting improved activity relative to the native insulin-like growth factor 1 and II polypeptide; The fusion component F is selected from the group consisting of a human IgG constant region, Fc domain, and heavy chain; muscle atrophy |
| 10/05/2006 | US20060223752 Of pestviruses as drug delivery devices for type-specific diagnosis of infection, for eliciting antibiotic activity, and for transport of substances into a cell |
| 10/05/2006 | US20060223751 bactericide, fungicide; defensins |
| 10/05/2006 | US20060223750 Agents and methods for enhancing photodynamic therapy |
| 10/05/2006 | US20060223748 Biologically active substance of a vasoactive intestinal peptide for treating interstitial lung infections |
| 10/05/2006 | US20060223747 Therapeutic agent for soft tissue sarcoma |
| 10/05/2006 | US20060223746 Injecting an alpha v beta 3 and/or alpha v beta 5 inhibitor, sufficient to inhibit or reduce angiogenesis or neovascularization in the treated eye, into the sclera layer of the eye; (2S)-2-benzyloxycarboxamido-3-(2-guanidinomethyl-1,4-benzodioxan-6-yl)propionic acid |
| 10/05/2006 | US20060223745 Macrocyclic compounds having aspartic protease inhibiting activity and pharmaceutical uses thereof |
| 10/05/2006 | US20060223744 Prostate specific antigens and uses thereof |
| 10/05/2006 | US20060223743 Metabolites of cyclosporin analogs |
| 10/05/2006 | US20060223741 of neuropathic pain comprising administering angiotensin II receptor 2 (AT2 receptor) antagonists such as 2-(Diphenylacetyl)-5-benzyloxy-6-methoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid |
| 10/05/2006 | US20060223740 Absorption enhancers such as e.g. bht, bha or propyl gallate |
| 10/05/2006 | US20060223180 Methods to mobilize progenitor/stem cells |
| 10/05/2006 | US20060223144 Method for mass production of human pollicle stimulating hormone |
| 10/05/2006 | US20060223143 Methods and compositions for polypeptide engineering |
| 10/05/2006 | US20060223121 Contacting biological sample of urine, cerebrospinal fluid or serum with a peptide and complexing with a monoclonal antibody ligand; detecting an immunogenic peptide having calgranulin B protein activity; Alzheimer's and Parkinson's disease, amyotrophic lateral sclerosis; rheumatoid arthritis |
| 10/05/2006 | US20060223112 Novel receptor |
| 10/05/2006 | US20060223109 G protein-coupled receptors |
| 10/05/2006 | US20060223104 promoting brown adipocyte differentiation by contacting a preadipocyte or a white adipocyte with a small interfering RNA (siRNA) that binds specifically to an mRNA encoding Necdin, wherein the siRNA selectively inhibits Necdin expression in an amount sufficient to increase Uncoupling Protein-1 expression |
| 10/05/2006 | US20060223082 Map |
| 10/05/2006 | US20060223055 Methods and compositions for treatment of viral lnfection |
| 10/05/2006 | US20060222717 Agent for Preventing and Curing Pathologies States Associated with Endorphin Deficiency in Organism |
| 10/05/2006 | US20060222716 Colloidal solid lipid vehicle for pharmaceutical use |
| 10/05/2006 | US20060222699 Flavored vegetarian cellulose capsule and methods for producing said capsule. |
| 10/05/2006 | US20060222698 hepatocyte targeted composition comprising mixture of free recombinant human insulin isophane and free recombinant human regular insulin and mixture of recombinant human insulin isophane and recombinant human regular insulin associated with water insoluble target molecule complex; diabetes treatment |
| 10/05/2006 | US20060222697 Hepatocyte delivery vehicle for delivery of a combination of recombinant human regular insulin and recombinant human insulin isophane to a mammal |
| 10/05/2006 | US20060222696 comprising one or more phosphatidylcholines, an N-( omega )-dicarboxylic acid-derivatized phosphatidyl ethanolamine, a targeting factor-modified N-( omega )-dicarboxylic acid-derivatized phosphatidyl ethanolamine, an encapsulated drug, cholesterol; cancer treatment |
| 10/05/2006 | US20060222692 Method and compositions for transdermal administration of antimicrobial medications |
| 10/05/2006 | US20060222677 Method of protecting sensitive molecules from a photo-polymerizing environment |
| 10/05/2006 | US20060222666 Clostridial toxin derivatives and methods for treating pain |
| 10/05/2006 | US20060222665 Virus vaccine |
| 10/05/2006 | US20060222662 Composition to be administered to a living being and method for marking agents |
| 10/05/2006 | US20060222652 Molecular antigen array |
| 10/05/2006 | US20060222649 Methods for inducing antigen-specific T cell tolerance |
| 10/05/2006 | US20060222648 Graft-versus-host disease; inhibit secretion of Interferon-gamma (IFN-?) by lymphocytes or other immune cells in a mammal; inflammatory bowel disease is Crohn's disease, ulcerative colitis, or ileitis; KIM-1 (Kidney Injury Molecule-1) |
| 10/05/2006 | US20060222647 Methods and compositions for modulating the activity of PDE5 |
| 10/05/2006 | US20060222641 Method and composition for preventing or reducing edema, deep vein thrombosis and/or pulmonary embolism |
| 10/05/2006 | US20060222640 New pharmaceutical compositions for treatment of thrombosis |
| 10/05/2006 | US20060222639 Wound treatment utilizing collagenase and a phosphotidylcholine organogel |
| 10/05/2006 | US20060222638 Cholesterol biosynthesis pathway modulators and uses thereof |
| 10/05/2006 | US20060222637 Proliferation of muc1 expressing cells |
| 10/05/2006 | US20060222631 Methods for therapeutic use of brain derived neurotrophic factor in the entorhinal cortex |
| 10/05/2006 | US20060222629 Compositions and methods for delivery of genetic material |
| 10/05/2006 | US20060222628 Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes and DNA viruses |
| 10/05/2006 | US20060222627 Optimizing pharmacodynamics of therapeutic agents for treating vascular tissue |
| 10/05/2006 | US20060222626 enhancing the tumoricidal activity of an isolated TNF protein comprising bonding to the TNF to polyethyleneglycol; increased circulating half-life of the TNF while not increasing its toxicity; antitumor or anticarcinogenic agents with reduced side effects |
| 10/05/2006 | US20060222625 Therapeutic uses of allogeneic myeloid progenitor cells |
| 10/05/2006 | US20060222624 Detoxified TNF and method of preparing |
| 10/05/2006 | US20060222622 Methods and compositions for preventing and treating radiation-induced skin reactions |
| 10/05/2006 | US20060222599 Inhalative powder formulations containing the CGRP-antagonist 1 [N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine |
| 10/05/2006 | US20060222597 Buccal, polar and non-polar sprays containing propofol |
| 10/05/2006 | DE19744127B4 Neue Vitamin D-Derivate mit Cyclopropylringen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung sowie ihre Verwendung zur Herstellung von Arzneimitteln New vitamin D derivatives with Cyclopropylringen in the side chains, processes and intermediates for their preparation and their use for the production of pharmaceuticals |
| 10/05/2006 | DE102005014247A1 Antibakterielle Amid-Makrozyklen VI Antibacterial amide macrocycles VI |
| 10/05/2006 | CA2819332A1 System and method for loading a beneficial agent into a medical device |
| 10/05/2006 | CA2610292A1 Proliferation of muc1 expressing cells |
| 10/05/2006 | CA2603386A1 Age inhibitors |
| 10/05/2006 | CA2603156A1 Use of calcitonin as combined treatment therapy for the management of inflammatory disease conditions |
| 10/05/2006 | CA2603052A1 Immunogenic egfr peptides comprising foreign t cell stimulating epitope |
| 10/05/2006 | CA2602755A1 Antibacterial amide-macrocycles v |
| 10/05/2006 | CA2602709A1 Isolation of inhibitor of ires-mediated translation |
| 10/05/2006 | CA2602584A1 Compositions and methods for the control, prevention, and treatment of obesity and eating disorders |
| 10/05/2006 | CA2602563A1 Combinations comprising at least one direct thrombin inhibitor for the treatment of thrombosis |
| 10/05/2006 | CA2602463A1 High affinity hiv t cell receptors |
| 10/05/2006 | CA2602261A1 Amylin and amylin agonists for treating psychiatric diseases and disorders |
| 10/05/2006 | CA2601860A1 Control of blood glucose in diabetes treatment using pulmonarily administered insulin in combination with basal insulin |
| 10/05/2006 | CA2601436A1 Methods for stimulating hair growth by administering bmps |
| 10/05/2006 | CA2598711A1 Vegf antagonist formulations |